2019 Healthcare Research Review

Report Scope:

With growing demand for better healthcare infrastructure and medical needs, the healthcare industry is expected to flourish in the future. The technological advancements and robust research and development in this space, is anticipated to boost this market in the coming years. The BCC market research reports cater to the current and future needs of the healthcare market, with insights drawn from secondary and primary research. The healthcare industry is evolving in all its sub-domains such as medical devices, diagnostics, hospital supplies, and biotechnology. This report provides insights on emerging healthcare segments such as point of care diagnostics, antihypertensives and minimally invasive surgical devices.

Although, the healthcare industry is prospering, the companies are struggling in implementing effective ways to enter the market and sustain the competition, with thorough market knowledge.

Chapter 1 Foreword
Foreword
Chapter 2 Point-of-Care Diagnostics: Technologies and Global Markets (HLC043F)
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and Intended Audience
Scope of Report
Defining POC Testing
Methodology
Analysts Credentials
Related BCC Research Reports
Report Summary
Major Findings
POC Product Segments
Blood Chemistry and Electrolytes
Cardiac Marker
Cholesterol Testing/Monitoring
Drug and Alcohol Screening
Glucose Testing and Monitoring
Infectious Disease Testing
Pregnancy and Fertility Testing
Hemoglobin and Hemostasis
Tumor Marker
Urinalysis/Urine Chemistry
Commonly Performed POC Tests
Multiplex POCT (xPOCT)
Significance of CLIA in the United States
International Market Size
Global Market Revenues
North America
Europe
Asia-Pacific
LAAM
Presence of Manufacturers in the Worldwide Market
Competitor Market Share
Blood Chemistry and Electrolyte Testing
Blood Chemistry Parameters
Electrolytes
CLIA Quality Control Requirements for Blood Gas Analysis
Market Size
xPOCT Market Share
Cardiac Marker Testing
Market Size
xPOCT Market Share
Cholesterol Testing
Market Size
xPOCT Market Share
Drug and Alcohol Abuse Testing
Market Size
xPOCT Market Share
Glucose Testing
Market Size
xPOCT Market Share
Infectious Disease Testing
Market Size
xPOCT Market Share
Pregnancy and Fertility Testing
Market Size
xPOCT Market Share
Hemoglobin/Hemostasis Testing
Hematology and Hemostasis
Hemostasis (Coagulation)
Market Size
xPOCT Market Share
Tumor Marker Testing
Fecal and Gastric Occult Blood
Bladder Tumor Antigen Test
Market Size
xPOCT Market Share
Urine Chemistry Testing
Market Size
xPOCT Market Share
Other POC Tests
Vaginal pH Tests
Thyroid Stimulating Hormone Tests
Male Reproductive Tests
Menopause
Dry Eye
Market Size
xPOCT Market Share
Chapter 3 The Market for Minimally Invasive Medical Devices (HLC051H)
Introduction
Reasons for Doing This Study
Study Goals and Objectives
Scope of Report
Information Sources
Methodology
Analysts Credentials
Related BCC Research Reports
Report Summary
Market Breakdown by Technology Type
Geographic Segments
Application Segments
Device and Equipment Segments
End-User Segments
Detailed Market Analysis
Minimally Invasive Gastrointestinal Surgery
Minimally Invasive Gynecological Surgery
Minimally Invasive Urological Surgery
Minimally Invasive Cosmetic Surgery
Minimally Invasive Thoracic Surgical Procedures
Minimally Invasive Cardiothoracic Surgery
Minimally Invasive Noncardiac Vascular Interventional Surgery
Minimally Invasive Orthopedic surgery
Market by Type of Device and Equipment
Industry Structure
Competition and Market Shares
Monitoring/Visualization Equipment
Robotics/Computer-Assisted Surgery
Electrosurgical Equipment
Surgical Instruments
Surgical Devices
The Outlook for Minimally Invasive Surgical Devices and Instruments
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Long-Term Outlook for Minimally Invasive Surgical Devices and Equipment
Chapter 4 Tissue Engineering and Regeneration: Technologies and Global Markets (HLC101D)
Introduction
Study Goals and Objectives
Scope of Report
Intended Audience
Source of Information and Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Market Overview
Progress and Promises for Tissue-Engineering Industry
Body Parts That Can be Replaced by Tissue Engineering
Nanotechnology for Tissue Regeneration
Effects of Nanotechnology on Stem Cell Behavior for Tissue Regeneration
Nanotechnology in Tissue Regeneration Applications
Gene Therapies: The Future of Tissue Engineering
Progress
Prospects
Stem Cell Technologies Boon to Tissue Engineering
Market Breakdown by Segment
Therapeutic Products
Cell Therapy
Tissue Vascularization
Cell Culturing
Small Molecules and Biologics
Tissue Engineering
Gene Therapy
Market Breakdown by Material
Synthetic Materials
Biodegradable Synthetic Polymers
Scaffolds: Medical Poly Lactic Acid
Artificial Vascular Graft Materials
Hydrogel Technology
Biologically Derived Materials
Collagen
Xenogenic Tissue
Genetically Engineered Materials
Market Breakdown by Application
Cardiovascular Disorders
Peripheral Vascular Disease Applications
Coronary Artery Disease
Oncology
Dermatology
Musculoskeletal
Orthopedics
Bone Repair and Replacement
Cartilage and Connective Tissue Damage
Market Breakdown by Region
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Other European Countries
Asia-Pacific
India
Japan
China
Australia
Rest of Asia-Pacific
Rest of the World
Cartilage and Bone Tissue-Engineering Products
Cardiovascular Disease Products
Central Nervous System-Related Injuries and Diseases
Chapter 5 Antihypertensives: Global Markets to 2023 (HLC159A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Market and Technology Background
Hypertension
Pathophysiology and Pathogenesis
Classification
Prevalence of Hypertension
Antihypertensive Drugs
Commonly Prescribed Antihypertensive Drugs
Side Effects of Antihypertensive Drugs
Contraindications of Major Antihypertensive Drugs
Resistant Hypertension
Market Breakdown by Drug Class
Global Antihypertensive Drug Market
Angiotensin-Converting Enzyme (ACE) Inhibitors
Market Size and Forecast
Market Analysis
Angiotensin II Receptor Blockers
Market Size and Forecast
Market Analysis
Beta Blockers
Market Size and Forecast
Market Analysis
Calcium Channel Blockers
Market Size and Forecast
Market Analysis
Diuretics
Market Size and Forecast
Market Analysis
Combination Drug
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis
Global Market for Antihypertensives by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
South America
Market Size and Forecast
Market Analysis
Middle East and Africa
Market Size and Forecast
Market Analysis
Chapter 6 Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176C)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Market Overview
Radiopharmaceuticals
Uses of Radiopharmaceuticals
Evolution and Transition: Radiopharmaceuticals
Radiotherapy
Ionizing Radiation
Non-ionizing Radiation
Evolution and Transition: Radiation Therapy
The Discovery Period: 1890s
Kilovoltage Era: 1900 to 1940
Megavoltage Era: 1946 to 1996
Computer-Assisted Era: 1996 to the Present
Market Potential
Regulatory Outlook
United States
Canada
Australia
India
European Union
Investment Analysis
Market Share Analysis
Segmentation Overview
Segmentation by Type: Radiotherapy
Segmentation by Type: Radiopharmaceuticals
Segmentation by Production Method
Segmentation by Technology
Radiopharmaceutical and Therapeutics Market, by Application
Geographic Overview
North America
Europe
Asia-Pacific
RoW
Global Radiopharmaceutical and Therapeutics Market by Type
Radiotherapy
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiotherapy
Radiopharmaceuticals
Diagnostics
Therapeutics
Global Radiopharmaceutical and Therapeutics Market by Production Method
Particle Accelerators (Cyclotrons)
Working of Particle Accelerators
Nuclear Reactors
Radionuclide Generators
Production of Radioisotopes Through Radionuclides
Global Radiopharmaceutical and Therapeutics Market by Technology
External Radiotherapy Market by Technology
Particle Therapy/Proton Beam Therapy
Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Tomotherapy
Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiotherapy by Technology
Pulsed-Dose-Rate (PDR) Brachytherapy
Low-Dose-Rate Brachytherapy
High-Dose-Rate (HDR) Brachytherapy
Systemic Radiotherapy by Technology
Comparison between Alpha and Beta Emitters
Global Radiopharmaceutical and Therapeutics Market by Application
External Beam Radiation Therapy
Treatment Planning for External Beam Radiation
Dosing and Treatment with External Beam Radiation
Electron-Emitting High-Energy Linear Accelerators (LINACS)
Internal Radiation Therapy
Applications of Internal Beam Radiation Therapy
Systemic Radiation Therapy
Applications of Systemic Radiation Therapy
Geographic Analysis
North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Rest of the World (ROW)
Latin America
Middle East and Africa
Industry Structure
Raw Material Procurement
Quality
Terms and Conditions
Cost-Effective Components
Manufacturing/Development Process
Distributors
End Users
New Development and Current Situation
Current Market Scenario
Current Developments in Radiopharmaceuticals and Therapies
Chapter 7 Chronic Kidney Disease: Global Markets and Technologies Through 2023 (HLC214A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Key Findings
Market Overview
The U.S.
Canada
Japan
Germany
France
Italy
The UK
Brazil
Other Countries - China, India and Spain
Market Segment Analysis
Segment Analysis, by Treatment Intervention
Pharmaceutical Drugs
Medical Device Interventions-Dialysis
Analysis of Medical Device Intervention, by Product
Analysis of Medical Device Intervention/Dialysis Market, by End User
Market Breakdown by Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
Italy
U.K.
Asia-Pacific
China
India
Japan
RoW
Latin America
Africa
Middle East
Chapter 8 Hospital Supplies: Global Markets to 2023 (HLC220A)
Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Market Definitions
Hospital Supplies
Disposable Hospital Supplies
Mobility Aids and Transportation Equipment
Operating Room Equipment
Patient Examination Devices
Sterilization and Disinfectant Equipment
Syringes and Needles
Market Breakdown by Product Type
Disposable Hospital Supplies
Market Size and Forecast
Market Competition
Operating Room Equipment
Operating Room Lights
Operating Room Tables
Market Size and Forecast
Market Competition
Syringes and Needles
Syringe Alternatives
Syringe Innovations
Warnings Against Reusing Plastic Syringes
Needlestick Safety
Market Size and Forecast
Market Competition
Mobility Aids and Transportation Equipment
Market Size and Forecast
Market Competition
Sterilization and Disinfectant Equipment
Steam Bulk and Tabletop Sterilizers
Ethylene Oxide Sterilizer
Market Size and Forecast
Market Competition
Patient Examination Devices
Thermometers
Stethoscopes
Market Size and Forecast
Market Competition
Other Hospital Supplies
Market Size and Forecast
Market Breakdown by End User
Market Size and Forecast
Market Breakdown by Region
North America
United States
Canada
Mexico
Europe
Germany
Russia
United Kingdom
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World (ROW)
Chapter 9 Blood Screening and Typing: Global Markets (HLC224A)
Introduction
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
Related BCC Research Reports
Report Summary
Key Findings
Market Definition
Blood Screening
Blood Grouping and Typing
Market Segment Analysis
Segment Analysis, by Technology
Immunoassay
Market Size and Forecast
Nucleic Acid Amplification Technology
Polymerase Chain Reaction Amplification
Other Nucleic Acid Amplification Technologies
Market Size and Forecast
Immunohematology (Blood Typing) Techniques
Manual Typing Methods
Automated Blood Typing
Market Size and Forecast
Microbial Techniques
Blood Stream Infections
Blood Cell Culture and Antimicrobial Susceptibility Testing
BioMerieuxs VITEK 2 System
Becton, Dickinson and Companys BD Phoenix Identification and Susceptibility Testing System
Market Size and Forecast
Niche Emerging Technologies
DNA Sequencing
Microarray
Market Size and Forecast
Segment Analysis, by End User
Reference Laboratories
Standalone Blood Banks
Hospitals
Segment Analysis, by Blood Type
Donor Blood
Patient Blood
Market Breakdown by Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of the World (RoW)
South America
Middle East and Africa
Market Share Analysis
Market Share Analysis in the Nucleic Acid Test Segment
Market Share Analysis in the Immunoassay Tests Segment
Market Share Analysis in the Immunohematology Segment
Market Share Analysis in the Microbiology Segment

List Of Tables


Table 1 : Selected CLIA-Waived POC Tests
Table 2 : Global Market Shares of xPOCT, by Segment, 2018
Table 3 : Global Market for POC Testing, by Test Type, Through 2023
Table 4 : North American Market for POC Testing, by Test Type, Through 2023
Table 5 : European Market for POC Testing, by Test Type, Through 2023
Table 6 : Asia-Pacific Market for POC Testing, by Test Type, Through 2023
Table 7 : LAAM Market for POC Testing, by Test Type, Through 2023
Table 8 : Global Market Share for POC Testing, by Major Participant, 2018
Table 9 : Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
Table 10 : Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
Table 11 : Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
Table 12 : Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
Table 13 : Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
Table 14 : Global Market Shares of Infectious Disease POC Tests, by Type, 2018
Table 15 : Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
Table 16 : Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
Table 17 : Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
Table 18 : Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
Table 19 : Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
Table 20 : Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
Table 21 : Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
Table 22 : Global Market for MIS Devices and Equipment Sales, Through 2024
Table 23 : Global Market for MIS Devices and Equipment Sales, by Country/Region, Through 2024
Table 24 : U.S. Market for MIS Devices and Equipment Sales, by Application, Through 2024
Table 25 : U.S. Market for MIS Devices and Equipment Sales, by Equipment Type, Through 2024
Table 26 : U.S. Market for MIS Devices and Equipment Sales, by End-User, Through 2024
Table 27 : Projected Number of Persons 18 Years and Older in the U.S., Through 2024
Table 28 : Projected Trends in Minimally Invasive Gastrointestinal Procedures, Through 2024
Table 29 : Projected U.S. Demand for MIS Devices and Equipment Used in Gastrointestinal Surgery, Through 2024
Table 30 : Projected Number of U.S. Women Aged Between 40 to 64 Years, Through 2024
Table 31 : Projected Trends in Minimally Invasive Gynecological Procedures, Through 2024
Table 32 : Projected U.S. Demand for MIS Devices and Equipment Used in Gynecological Surgery, Through 2024
Table 33 : Number of New Cases of Selected Cancers, Through 2019
Table 34 : Trends in Number of U.S. Women Aged over 45 Years, Through 2024
Table 35 : Trends in Number of U.S. Boys Aged under Five Years, Through 2024
Table 36 : Projected Trends in Minimally Invasive Urological Procedures, Through 2024
Table 37 : Projected U.S. Demand for MIS Devices and Equipment Used in Urological Surgery, Through 2024
Table 38 : Number of U.S. Cosmetic Surgery Procedures, Through 2018
Table 39 : Projected Trends in Minimally Invasive Cosmetic Surgical Procedures, Through 2024
Table 40 : Projected U.S. Demand for MIS Devices and Equipment Used in Cosmetic Surgery, Through 2024
Table 41 : Trends in U.S. Lung Cancer Disease, Through 2019
Table 42 : Projected Trends in Minimally Invasive Thoracic Procedures, Through 2024
Table 43 : Projected U.S. Demand for MIS Devices and Equipment Used in Thoracic Surgery, Through 2024
Table 44 : Projected U.S. Demand for MIS Devices and Equipment Used in Cardiac Surgery, Through 2024
Table 45 : Projected U.S. Demand for MIS Devices and Equipment Used in Vascular Surgery, Through 2024
Table 46 : Projected Trends in Minimally Invasive Orthopedic Procedures, Through 2024
Table 47 : Projected U.S. Demand for MIS Devices and Equipment Used in Orthopedic Surgery, Through 2024
Table 48 : Projected U.S. Market for MIS Device and Equipment Sales, by Application, Through 2024
Table 49 : U.S. Medical and Surgical Equipment Manufacturers, by Employment Size and Sales Category, 2012
Table 50 : Trends in Age Composition of the Worlds Population, Through 2025
Table 51 : Projected Trends in Per-Capita Real Gross Domestic Product (GDP) Growth, by Region, 2018-2021
Table 52 : Global Market for Tissue Engineering and Regeneration, by Region, Through 2023
Table 53 : U.S. and European Differences in Regulatory Approval
Table 54 : Global Market for Tissue Engineering and Regeneration, by Segment, Through 2023
Table 55 : Global Market for Tissue Engineering and Regeneration, by Therapeutic Product, Through 2023
Table 56 : Autologous vs. Allogenic Cells: Manufacturing Process
Table 57 : Global Market for Cell Therapy, by Region, Through 2023
Table 58 : Stem Cells, Advantages and Clinical Trials on Cardiovascular Disease Treatments
Table 59 : Types of Urinary Bladder Scaffolds Proposed, 2011-2017
Table 60 : Investments in Cell Culture Technology, 2017-2018
Table 61 : Projects and Their Assessment Stages, 2017
Table 62 : FDA New Molecular Entity Approval Attributes, 2017 and 2018
Table 63 : Global Market for Tissue-Engineering, by Region, Through 2023
Table 64 : Global Market for Gene Therapy, by Region, Through 2023
Table 65 : Global Market for Tissue Engineering and Regeneration, by Therapeutic Material, Through 2023
Table 66 : Global Market for Synthetic Materials, by Type, Through 2023
Table 67 : Global Market for Synthetic Materials, by Region, Through 2023
Table 68 : Biodegradable Polymer Classification
Table 69 : Global Market for Biodegradable Synthetic Polymers, by Region, Through 2023
Table 70 : Commercial Polymeric Scaffold Products
Table 71 : Global Market for Scaffolds, by Region, Through 2023
Table 72 : Tissue Engineered Vascular Graft Utilized in Human Studies, 2011-2017
Table 73 : Global Market for Artificial Vascular Grafts, by Region, Through 2023
Table 74 : Global Market for Hydrogel Technology, by Region, Through 2023
Table 75 : Global Market for Biologically Derived Materials, by Type, Through 2023
Table 76 : Global Market for Biologically Derived Materials, by Region, Through 2023
Table 77 : Global Market for Biologically Derived Collagen, by Region, Through 2023
Table 78 : Commercially Available Xenogeneic Acellular Graft
Table 79 : Global Market for Biologically Derived Xenogenic Tissue, by Region, Through 2023
Table 80 : Global Market for Genetically Engineered Materials, by Type, Through 2023
Table 81 : Global Market for Genetically Engineered Materials, by Region, Through 2023
Table 82 : Global Market for Deoxyribonucleic Acid Transfection Vectors, by Region, Through 2023
Table 83 : Global Market for Genetically Manipulated Cells, by Region, Through 2023
Table 84 : Global Market for 3D Polymer Technology, by Region, Through 2023
Table 85 : List of Polymer Scaffolds Fabricated for Tissue Engineering Utilizing 3D Printing
Table 86 : Global Market for Transgenics in Tissue Engineering, by Region, Through 2023
Table 87 : Global Market for Fibroblasts, by Region, Through 2023
Table 88 : Commercially Available Fibroblast Based Skin Substitute
Table 89 : Global Market for Neural Stem Cells, by Region, Through 2023
Table 90 : Global Market for Gene-Activated Matrix, by Region, Through 2023
Table 91 : List of Biologics Approved, 2017
Table 92 : Global Market for Small Molecules and Biologics, by Region, Through 2023
Table 93 : Global Market for Tissue Engineering and Regeneration, by Application, Through 2023
Table 94 : Global Market for Tissue-Engineering and Regeneration in Cardiovascular Applications, by Region, Through 2023
Table 95 : Cell Therapies by Different Companies to Treat Cardiovascular Diseases
Table 96 : Global Market for Tissue-Engineering and Regeneration in Oncology, by Region, Through 2023
Table 97 : Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
Table 98 : Acellular Skin Tissue-Engineered Products in the Market
Table 99 : Cellular Skin Tissue-Engineered Products in the Market
Table 100 : Global Market for Tissue-Engineering and Regeneration in Dermatology Applications, by Region, Through 2023
Table 101 : Global Market for Tissue-Engineering and Regeneration in Musculoskeletal Applications, by Region, Through 2023
Table 102 : Orthopedic Diseases, by Region: Key Facts
Table 103 : Regenerative Medicine Companies, by Size and Region, 2011
Table 104 : Global Market for Tissue-Engineering and Regeneration, by Region, Through 2023
Table 105 : North American Commercialized Tissue-Engineering Products
Table 106 : North American Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
Table 107 : Tissue Engineering Research Conducted according to Different Universities
Table 108 : Tissue-Engineering Products Offered by Different Companies
Table 109 : Funds Allocated for Research Activities in Budget, 2016
Table 110 : Share of Increase of Spending on Biologics in Canada, 2011-2016
Table 111 : Shares of Tissue-Engineering Firms in Selected European Countries, 2016
Table 112 : European Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
Table 113 : Number of Deaths across Germany on Gender Differentiation, by Cause of Death, 2017
Table 114 : Companies That Target Different Tissue-Engineering Areas in Germany
Table 115 : Different Causes of Death: U.K. Statistics, 2017
Table 116 : Companies That Target Different Tissue Engineering Areas in the U.K.
Table 117 : Companies That Target Different Tissue Engineering Areas in France
Table 118 : European Stem Cell Policies, by Country
Table 119 : European Companies Developing Products in Tissue Engineering and Regeneration for Central Nervous System Disorders and Injuries
Table 120 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Segment, Through 2023
Table 121 : Rest of the World Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
Table 122 : Global Statistics for Central Nervous System Disorders and Injuries, 2015
Table 123 : Classification of Hypertension or Blood Pressure
Table 124 : Global Prevalence of Hypertension with Population Aged 18 Years or Older, by Country, 2015
Table 125 : Commonly Prescribed Antihypertensive Drugs
Table 126 : Side Effects with Different Classes of Antihypertensive Drugs
Table 127 : Contraindications of Major Antihypertensive Drugs
Table 128 : Global Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 129 : Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, by Region, Through 2023
Table 130 : ACE Inhibitors Drug, Branded/Generic FDA Approval
Table 131 : Global Market for Angiotensin II Receptor Blockers (ARBs), by Region, Through 2023
Table 132 : Global Market for Beta Blocker Drugs, by Region, Through 2023
Table 133 : Global Market for Calcium Channel Blocker Drugs, by Region, Through 2023
Table 134 : Global Market for Diuretics Drugs, by Region, Through 2023
Table 135 : Global Market for Combination Drugs, by Region, Through 2023
Table 136 : Commonly Prescribed Combinations of Antihypertensive Drugs
Table 137 : Global Market for Other Antihypertensive Drugs, by Region, Through 2023
Table 138 : Commonly Prescribed Types of Other Antihypertensive Drugs
Table 139 : Global Market for Antihypertensive Drugs, by Region, Through 2023
Table 140 : North American Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 141 : North American Market for Antihypertensive Drugs, by Country, Through 2023
Table 142 : Total Number of High Blood Pressure Patients in Canada, by Age Group, 2016 and 2017
Table 143 : European Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 144 : European Market for Antihypertensive Drugs, by Country, Through 2023
Table 145 : Asia-Pacific Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 146 : Asia-Pacific Market for Antihypertensive Drugs, by Country, Through 2023
Table 147 : South American Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 148 : Middle Eastern and African Market for Antihypertensive Drugs, by Drug Class, Through 2023
Table 149 : Milestones in the Discovery of Radioactivity and Nuclear Medicine
Table 150 : Prevalence of Different Cancers in Top Countries, 2016
Table 151 : Deaths from Cancers in Top Countries, by Cancer Type, 2016
Table 152 : Summary of Regulatory Affairs Across Countries
Table 153 : Investments in Radiopharmaceutical and Therapeutics Market
Table 154 : Global Radiopharmaceutical Market Share Analysis, by Company, 2017
Table 155 : Global Therapeutics Market Share Analysis, by Company, 2017
Table 156 : Global Radiotherapy Market, by Type, Through 2023
Table 157 : Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
Table 158 : Global Cancer Deaths, by Type, 2016
Table 159 : Global External Beam Radiotherapy Market, by Type, Through 2023
Table 160 : Global External Beam Radiotherapy Market, by Region, Through 2023
Table 161 : Global Electron-Emitting High-Energy Linear Accelerators Market, by Region, Through 2023
Table 162 : Global Compact Radiotherapy System Market, by Type, Through 2023
Table 163 : Global Compact Radiotherapy System Market, by Region, Through 2023
Table 164 : Global CyberKnife Market, by Region, Through 2023
Table 165 : Global Prevalence of Dementia, 2015, 2030 and 2050
Table 166 : Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
Table 167 : Global Gamma Knife Market, by Region, Through 2023
Table 168 : Global Proton Therapy System Market, by Type, Through 2023
Table 169 : Global Proton Therapy System Market, by Region, Through 2023
Table 170 : Global Cyclotron Market, by Region, Through 2023
Table 171 : Global Synchrotron Market, by Region, Through 2023
Table 172 : Global Internal Radiotherapy/Brachytherapy Market, by Type, Through 2023
Table 173 : Global Internal Radiotherapy/Brachytherapy Market, by Region, Through 2023
Table 174 : Global Brachytherapy Seed Market, by Region, Through 2023
Table 175 : Global Applicator and Afterloader Market, by Region, Through 2023
Table 176 : Global External Brachytherapy Market, by Region, Through 2023
Table 177 : Global Systemic Radiotherapy Market, by Region, Through 2023
Table 178 : Global Systemic Radiotherapy Market, by Type, Through 2023
Table 179 : Global Radiopharmaceutical Market, by Type, Through 2023
Table 180 : Global Deaths Caused by Chronic Diseases, by Type, 2015
Table 181 : Pharmaceutical Spending Share, by Country, 2016 (As a Percentage of Health Spending)
Table 182 : Global Diagnostic Radiopharmaceutical Market, by Type, Through 2023
Table 183 : Global Diagnostic Radiopharmaceutical Market, by Region, Through 2023
Table 184 : Global PET Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
Table 185 : Global SPECT Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
Table 186 : Global Other Diagnostic Radiopharmaceuticals Market, by Type of Radionuclide, Through 2023
Table 187 : Global Therapeutic Radiopharmaceutical Market, by Type of Therapeutic, Through 2023
Table 188 : Global Therapeutic Radiopharmaceutical Market, by Region, Through 2023
Table 189 : Global Alpha Emitter Market, by Type of Radionuclide, Through 2023
Table 190 : Global Beta Emitters Market, by Type of Radionuclide, Through 2023
Table 191 : Global Brachytherapy Seeds Market, by Type of Radionuclide, Through 2023
Table 192 : Global Radiopharmaceuticals Market, by Production Method, Through 2023
Table 193 : Comparison of External Beam Radiation Therapy (EBRT) and Brachytherapy
Table 194 : Comparison of Technologies in Radiotherapy
Table 195 : Global External Radiotherapy Market, by Technology, Through 2023
Table 196 : Global Particle Therapy Market, by Region, Through 2023
Table 197 : Global Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy Market, by Region, Through 2023
Table 198 : Global Image-Guided Radiotherapy Market, by Region, Through 2023
Table 199 : Global Intensity-Modulated Radiotherapy Market, by Region, Through 2023
Table 200 : Comparison of Tomotherapy and Conventional Radiotherapy
Table 201 : Global Tomotherapy Market, by Region, Through 2023
Table 202 : Global Three-Dimensional Conformal Radiotherapy Market, by Region, Through 2023
Table 203 : Global Volumetric Modulated ARC Therapy Market, by Region, Through 2023
Table 204 : Advantages and Disadvantages of Brachytherapy
Table 205 : Various Types of Brachytherapy Implants
Table 206 : Brachytherapy Treatment Duration
Table 207 : Brachytherapy Treatment Dose Rate
Table 208 : Brachytherapy Treatment Source Loading
Table 209 : Comparison of Low-Dose and High-Dose Radiation Therapy
Table 210 : Benefits and Drawbacks of High-Dose-Rate (HDR) Brachytherapy
Table 211 : Comparison of Alpha and Beta Particles
Table 212 : Benefits and Drawbacks of Radiopharmaceuticals
Table 213 : Mechanisms of Radiopharmaceutical Localization
Table 214 : Global Radiotherapy Market, by Application, Through 2023
Table 215 : Global Number of Cancer Cases, 2012 and 2030
Table 216 : Estimates for Lung Cancer in the United States for 2018
Table 217 : Global External Beam Radiotherapy Market, by Application, Through 2023
Table 218 : Global Internal Beam Radiotherapy Market, by Application, Through 2023
Table 219 : Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
Table 220 : Global Systemic Radiotherapy Market, by Application, Through 2023
Table 221 : Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
Table 222 : North American Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 223 : New Cancer Cases and Estimated Deaths, 2016
Table 224 : Aging U.S. Population, 2000-2050
Table 225 : North American Radiotherapy Market, by Type, Through 2023
Table 226 : New HIV Diagnoses in the United States, by Age Group, 2016
Table 227 : Healthcare Expenditures, by Source, Canada, 2015 and 2040
Table 228 : North American Radiopharmaceutical Market, by Type, Through 2023
Table 229 : Rising Aging Population (65 Years and Older) in Canada, 1996-2016
Table 230 : European Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 231 : European Radiotherapy Market, by Type, Through 2023
Table 232 : Estimated Number of People Living with Cancer in U.K., by Country, 2015 and 2020
Table 233 : European Radiopharmaceutical Market, by Type, Through 2023
Table 234 : Health Spending and Financing, 2005-2015
Table 235 : Rising Geriatric Population in Germany, 2000-2030
Table 236 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Table 237 : Estimate of Elderly People with Dementia (Aged 60+) in Denmark, 2017-2040
Table 238 : Asia-Pacific Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 239 : Asia-Pacific Radiotherapy Market, by Type, Through 2023
Table 240 : Number of People with Cancer in China, 2010-2016
Table 241 : R&D Spending in India, by Top Pharmaceutical Companies
Table 242 : Japanese Pharmaceutical Industry, 2010-2015
Table 243 : Estimated Most Commonly Diagnosed Cancers, by Type, 2018
Table 244 : Commonly Diagnosed Cancer Cases in Australia, by Gender and Cancer Type, 2017
Table 245 : Asia-Pacific Radiopharmaceutical Market, by Type, Through 2023
Table 246 : Rest of World Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
Table 247 : Number of Cyclotrons Operating in Brazil, 2010-2015
Table 248 : Rest of the World Radiotherapy Market, by Type, Through 2023
Table 249 : Leading Causes of Deaths Related to Cancer in the UAE, by Cancer Type, 2015
Table 250 : Rest of the World Radiopharmaceutical Market, by Type, Through 2023
Table 251 : Global Suppliers for the Radiopharmaceutical and Therapeutics Market
Table 252 : Selected Manufacturers of Instruments in Radiopharmaceutical and Therapeutics Market
Table 253 : Cancer Deaths in Top Countries, by Type of Cancer, 2016
Table 254 : Global Market for Chronic Kidney Disease, by Type, Through 2023
Table 255 : Reimbursement of Dialysis Services per Week, 2011-2013
Table 256 : Global Market for CKD Pharmaceutical Drugs, by Type, Through 2023
Table 257 : Global Market for CKD Stage 1-5 Drugs, by Region, Through 2023
Table 258 : Common Drug Classes Used, by Part D-Enrolled Dialysis Patients, 2013
Table 259 : Global Market for Dialysis Drugs, by Region, Through 2023
Table 260 : Global Market for Post-Transplantation Drugs, by Region, Through 2023
Table 261 : Global Market for Dialysis Devices, by Type, Through 2023
Table 262 : Global Market for Hemodialysis, by Region, Through 2023
Table 263 : Key Peritoneal Products and Manufacturers
Table 264 : Global Market for Peritoneal Dialysis, by Region, Through 2023
Table 265 : Global Market for Dialysis Devices, by Product, Through 2023
Table 266 : Global Market for Dialysis Accessories, by Region, Through 2023
Table 267 : Global Market for Dialysis Equipment, by Region, Through 2023
Table 268 : Global Market for Dialysate and Other Solutions, by Region, Through 2023
Table 269 : Global Market for Dialysis Devices, by End User, Through 2023
Table 270 : Global Market for Medical Care Centers, by Region, Through 2023
Table 271 : Global Market for In-Home Dialysis, by Region, Through 2023
Table 272 : Global Market for Chronic Kidney Disease, by Region, Through 2023
Table 273 : North American Market for Chronic Kidney Disease, by Country, Through 2023
Table 274 : European Market for Chronic Kidney Disease, by Country, Through 2023
Table 275 : Asia-Pacific Market for Chronic Kidney Disease, by Country, Through 2023
Table 276 : Rest of the World Market for Chronic Kidney Disease, by Country, Through 2023
Table 277 : Global Market for Hospital Supplies, by Product Type, Through 2023
Table 278 : Global Hospital Supply Market, by Product Type, Through 2023
Table 279 : Global Disposable Hospital Supply Market, by Region, Through 2023
Table 280 : Global Operating Room Equipment Market, by Region, Through 2023
Table 281 : Global Syringe and Needle Market, by Region, Through 2023
Table 282 : Global Mobility and Transportation Equipment Market, by Region, Through 2023
Table 283 : Global Sterilization and Disinfectant Equipment Market, by Region, Through 2023
Table 284 : Global Patient Examination Device Market, by Region, Through 2023
Table 285 : Global Other Hospital Supply Market, by Region, Through 2023
Table 286 : Global Hospital Supply Market, by End User, Through 2023
Table 287 : North American Hospital Supply Market, by End User, Through 2023
Table 288 : Asia-Pacific Hospital Supply Market, by End User, Through 2023
Table 289 : European Hospital Supply Market, by End User, Through 2023
Table 290 : Rest of the World Hospital Supply Market, by End User, Through 2023
Table 291 : Global Hospital Supply Market, by Region, Through 2023
Table 292 : North American Hospital Supply Market, by Country, Through 2023
Table 293 : North American Hospital Supply Market, by Product Type, Through 2023
Table 294 : European Hospital Supply Market, by Country, Through 2023
Table 295 : European Hospital Supply Market, by Product Type, Through 2023
Table 296 : Asia-Pacific Hospital Supply Market, by Country, Through 2023
Table 297 : Asia-Pacific Hospital Supply Market, by Product Type, Through 2023
Table 298 : Chinese Market Statistics
Table 299 : Japanese Market Statistics
Table 300 : Rest of the World Hospital Supply Market, by Product Type, Through 2023
Table 301 : Rest of the World Hospital Supply Market, by End User, Through 2023
Table 302 : Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 303 : Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 304 : Global Market for Immunoassay Tests, by Region, Through 2023
Table 305 : Selected PCR Screening Tests, by Type
Table 306 : Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
Table 307 : Global Market for Immunohematology Devices, by Region, Through 2023
Table 308 : Global Market for Microbial Techniques, by Region, Through 2023
Table 309 : Global Market for Niche Technologies, by Region, Through 2023
Table 310 : Global Market for Blood Screening and Typing, by End User, Through 2023
Table 311 : Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
Table 312 : Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
Table 313 : Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
Table 314 : Global Market for Blood Screening and Typing, by Type, Through 2023
Table 315 : Global Market for Donor Blood Testing Equipment, by Region, Through 2023
Table 316 : Global Market for Patient Blood Testing Equipment, by Region, Through 2023
Table 317 : Global Market for Blood Screening and Typing, by Region, Through 2023
Table 318 : North American Market for Blood Screening and Typing, by Country, Through 2023
Table 319 : European Market for Blood Screening and Typing, by Country, Through 2023
Table 320 : Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
Table 321 : Donation and Distribution (JRCS 2015)
Table 322 : RoW Market for Blood Screening and Typing, by Country, Through 2023
Table 323 : Leading Companies, by Technology Segment

List Of Figures


Figure 1 : Global Market for POC Testing, by Test Type, 2017-2023
Figure 2 : Global Market Share for POC Testing, by Test Type, 2018
Figure 3 : Global Market Shares for POC Testing, by Major Participant, 2018
Figure 4 : Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
Figure 5 : Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
Figure 6 : Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
Figure 7 : Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
Figure 8 : Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
Figure 9 : Global Market Shares of Infectious Disease POC Tests, by Type, 2018
Figure 10 : Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
Figure 11 : Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
Figure 12 : Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
Figure 13 : Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
Figure 14 : Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
Figure 15 : Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
Figure 16 : Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
Figure 17 : Global Market for MIS Devices and Equipment Sales, 2018-2024
Figure 18 : Global Market Shares of MIS Devices and Equipment Sales, by Country/Region, 2018 vs. 2024
Figure 19 : U.S. Market Shares of MIS Devices and Equipment Sales, by Application, 2018 vs. 2024
Figure 20 : U.S. Market Shares of MIS Devices and Equipment Sales, by Equipment Type, 2018 vs. 2024
Figure 21 : U.S. Market Shares of MIS Devices and Equipment Sales, by End-User, 2018 vs. 2024
Figure 22 : U.S. Market Shares of MIS Devices and Equipment Used in Gastrointestinal Surgery, 2018
Figure 23 : U.S. Market Shares of MIS Devices and Equipment Used in Gynecological Surgery, 2018
Figure 24 : U.S. Market Shares of MIS Devices and Equipment Used in Urological Surgery, 2018
Figure 25 : U.S. Market Shares of MIS Devices and Equipment Used in Cosmetic Surgery, 2018
Figure 26 : U.S. Market Shares of MIS Devices and Equipment Used in Thoracic Surgery, 2018
Figure 27 : U.S. Market Shares of MIS Devices and Equipment Used in Cardiac Surgery, 2018
Figure 28 : U.S. Market Shares of MIS Devices and Equipment Used in Noncardiac Vascular Surgery, 2018
Figure 29 : U.S. Market Shares of MIS Devices and Equipment Used in Orthopedic Surgery, 2018
Figure 30 : Employee Numbers and Sales Distribution of U.S. Medical and Surgical Equipment Manufacturers, 2012
Figure 31 : Percentage Distribution of Monitoring/Visualization Equipment, by Market Leader, 2018
Figure 32 : Percentage Distribution of Robotics/Computer-Assisted Surgery, by Market Leader, 2018
Figure 33 : Percentage Distribution of Global Electrosurgical and Auxiliary Equipment, by Market Leader, 2018
Figure 34 : Percentage Distribution of Endosurgical Instrument, by Market Leader, 2018
Figure 35 : Percentage Distribution of Coronary Stent, by Market Leader, 2018
Figure 36 : Global Market for Tissue Engineering and Regeneration, by Region, 2017-2023
Figure 37 : Tissue-Engineering Strategies
Figure 38 : Nanotechnology and Tissue Regeneration
Figure 39 : FDA Approvals of Biologics, 2016-2018
Figure 40 : Shares of Global Diabetes Prevalence, by Region, 2017
Figure 41 : T-Cell Therapy Technique
Figure 42 : Global Number of Orthopedic Surgeries, 2012-2020
Figure 43 : Regenerative Medicine Companies, by Size and Region, 2011
Figure 44 : United States NIH Stem Cell Research Spending, 2013-2018
Figure 45 : Shares of Heart Disease Deaths in the U.S., by Disease Type, 2017
Figure 46 : Healthcare Spending in Germany, by Source, 2015 and 2040 (est.)
Figure 47 : Pathway for Dissemination of Regenerative Medicine
Figure 48 : Global Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 49 : Global Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 50 : Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, 2017-2023
Figure 51 : Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, by Region, 2017-2023
Figure 52 : Global Market for Angiotensin II Receptor Blockers (ARBs), 2017-2023
Figure 53 : Global Market for Angiotensin II Receptor Blockers (ARBs), by Region, 2017-2023
Figure 54 : Leading ARBs Drug Prescriptions in the U.S., 2016
Figure 55 : Global Market for Beta Blocker Drugs, 2017-2023
Figure 56 : Global Market for Beta Blocker Drugs, by Region, 2017-2023
Figure 57 : Global Market for Calcium Channel Blocker Drugs, 2017-2023
Figure 58 : Global Market for Calcium Channel Blocker Drugs, by Region, 2017-2023
Figure 59 : Global Market for Diuretics Drugs, 2017-2023
Figure 60 : Global Market for Diuretics Drugs, by Region, 2017-2023
Figure 61 : Global Market for Combination Drugs, 2017-2023
Figure 62 : Global Market for Combination Drugs, by Region, 2017-2023
Figure 63 : Global Market for Other Antihypertensive Drugs, 2017-2023
Figure 64 : Global Market for Other Antihypertensive Drugs, by Region, 2017-2023
Figure 65 : Global Market Shares for Antihypertensive Drugs, by Region, 2017
Figure 66 : North American Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 67 : North American Market Shares for Antihypertensive Drugs, by Country, 2017
Figure 68 : U.S. Market for Antihypertensive Drugs, 2017-2023
Figure 69 : Canadian Market for Antihypertensive Drugs, 2017-2023
Figure 70 : Mexican Market for Antihypertensive Drugs, 2017-2023
Figure 71 : European Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 72 : European Market Shares for Antihypertensive Drugs, by Country, 2017
Figure 73 : German Market for Antihypertensive Drugs, 2017-2023
Figure 74 : French Market for Antihypertensive Drugs, 2017-2023
Figure 75 : U.K. Market for Antihypertensive Drugs, 2017-2023
Figure 76 : Italian Market for Antihypertensive Drugs, 2017-2023
Figure 77 : Spanish Market for Antihypertensive Drugs, 2017-2023
Figure 78 : Rest of Europe Market for Antihypertensive Drugs, 2017-2023
Figure 79 : Asia-Pacific Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 80 : Asia-Pacific Market Shares for Antihypertensive Drugs, by Country, 2017
Figure 81 : Japanese Market for Antihypertensive Drugs, 2017-2023
Figure 82 : Chinese Market for Antihypertensive Drugs, 2017-2023
Figure 83 : Indian Market for Antihypertensive Drugs, 2017-2023
Figure 84 : Rest of Asia-Pacific Market for Antihypertensive Drugs, 2017-2023
Figure 85 : South American Market for Antihypertensive Drugs, 2017-2023
Figure 86 : South American Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 87 : Middle Eastern and African Market for Antihypertensive Drugs, 2017-2023
Figure 88 : Middle East and African Market Shares for Antihypertensive Drugs, by Drug Class, 2017
Figure 89 : Types of Radiation
Figure 90 : Prevalence of Different Types of Cancers in Top Countries, 2016
Figure 91 : Deaths from Cancers in Top Countries, by Cancer Type, 2016
Figure 92 : Global Radiopharmaceutical Market Share Analysis, by Company, 2017
Figure 93 : Global Therapeutics Market Share Analysis, by Company, 2017
Figure 94 : Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
Figure 95 : Global Cancer Deaths, by Type, 2016
Figure 96 : Types of Beams Used in Radiation Therapy
Figure 97 : Common Types of Compact Advance Radiotherapy Systems
Figure 98 : Global Prevalence of Dementia, 2015, 2030 and 2050
Figure 99 : Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
Figure 100 : Global Deaths Caused by Chronic Diseases, by Type, 2015
Figure 101 : Pharmaceutical Spending Share, by Country, 2016
Figure 102 : Different Types of Diagnostic Radiopharmaceuticals
Figure 103 : Types of Therapeutic Radiopharmaceuticals
Figure 104 : Different Production Techniques of Radiopharmaceuticals
Figure 105 : Block Diagram of Particle Accelerators
Figure 106 : Block Diagram of External Radiotherapy Technologies
Figure 107 : Block Diagram of Particle Therapy/Proton Beam Therapy
Figure 108 : Block Diagram of Stereotactic Radiosurgery
Figure 109 : Procedure of Image-Guided Radiotherapy (IGRT)
Figure 110 : Block Diagram of Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Figure 111 : Procedure of LDR Prostate Brachytherapy
Figure 112 : Types of External Radiation Therapy
Figure 113 : Global Number of Cancer Cases, 2012 and 2030
Figure 114 : Estimated New Cases of Leukemia, Lymphoma, and Myeloma, 2018
Figure 115 : New HIV Diagnoses in the United States, by Age Group, 2016
Figure 116 : Canadian Healthcare Expenditures, by Source, 2015 and 2040
Figure 117 : Rising Aging Population (65 Years and Older) in Canada, 1996-2016
Figure 118 : Health Spending and Financing, 2005-2015
Figure 119 : Rising Geriatric Population in Germany, 2000-2030
Figure 120 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Figure 121 : Number of People with Cancer in China, 2010-2016
Figure 122 : R&D Spending in India, by Top Pharmaceutical Companies, 2017
Figure 123 : Japanese Pharmaceutical Industry, 2010-2015
Figure 124 : Estimated Most Commonly Diagnosed Cancers, by Type, 2018
Figure 125 : Industry Structure of Instruments and Medicines in the Radiopharmaceutical and Therapeutics Market
Figure 126 : Global Market Shares of Hospital Supplies, by Product Type, 2017
Figure 127 : Global Hospital Supply Market, 2017-2023
Figure 128 : Global Hospital Supply Market Shares, by Product Type, 2017
Figure 129 : Global Disposable Hospital Supply Market Shares, by Region, 2017
Figure 130 : Global Operating Room Equipment Market Shares, by Region, 2017
Figure 131 : Global Syringe and Needle Market Shares, by Region, 2017
Figure 132 : Global Mobility and Transportation Equipment Market Shares, by Region, 2017
Figure 133 : Global Sterilization and Disinfectant Equipment Market Shares, by Region, 2017
Figure 134 : Global Patient Examination Device Market Shares, by Region, 2017
Figure 135 : Global Other Hospital Supply Market Shares, by Region, 2017
Figure 136 : Global Hospital Supply Market Shares, by End User, 2017
Figure 137 : North American Hospital Supply Market Shares, by End User, 2017
Figure 138 : Asia-Pacific Hospital Supply Market Shares, by End User, 2017
Figure 139 : European Hospital Supply Market Shares, by End User, 2017
Figure 140 : Rest of the World Hospital Supply Market Shares, by End User, 2017
Figure 141 : Global Hospital Supply Market Shares, by Region, 2017
Figure 142 : Global Hospital Supply Market, by Region, 2017-2023
Figure 143 : North American Hospital Supply Market Shares, by Product Type, 2017
Figure 144 : European Hospital Supply Market, by Country, 2017-2023
Figure 145 : European Hospital Supply Market, by Product Type, 2017-2023
Figure 146 : Asia-Pacific Hospital Supply Market Shares, by Product Type, 2017
Figure 147 : Rest of the World Hospital Supply Market Shares, by Product Type, 2017
Figure 148 : Rest of the World Hospital Supply Market Shares, by End User, 2017
Figure 149 : Global Market for Blood Screening and Typing, by Technology, 2017-2023
Figure 150 : Global Market Shares for Blood Screening and Typing, by Technology, 2017
Figure 151 : Global Market for Blood Screening and Typing, by Technology, 2017-2023
Figure 152 : Global Market Shares for Blood Screening and Typing, by Technology, 2017
Figure 153 : Global Market for Immunoassay Tests, by Region, 2017-2023
Figure 154 : Global Market Shares for Immunoassay Tests, by Region, 2017
Figure 155 : Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
Figure 156 : Global Market Shares for Nucleic Acid Amplification Technology, by Region, 2017
Figure 157 : Global Market for Immunohematology Devices, by Region, 2017-2023
Figure 158 : Global Market Shares for Immunohematology Devices, by Region, 2017
Figure 159 : Global Market for Microbial Techniques, by Region, 2017-2023
Figure 160 : Global Market Shares for Microbial Techniques, by Region, 2017
Figure 161 : Global Market for Niche Technologies, by Region, 2017-2023
Figure 162 : Global Market Shares for Niche Technologies, by Region, 2017
Figure 163 : Global Market for Blood Screening and Typing, by End User, 2017-2023
Figure 164 : Global Market Shares for Blood Screening and Typing, by End User, 2017
Figure 165 : Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
Figure 166 : Global Market Shares for Blood Screening and Typing in Reference Laboratories, by Region, 2017
Figure 167 : Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
Figure 168 : Global Market Shares for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
Figure 169 : Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
Figure 170 : Global Market Shares for Blood Screening and Typing in Hospitals, by Region, 2017
Figure 171 : Global Market for Blood Screening and Typing, by Type, 2017-2023
Figure 172 : Global Market Shares for Blood Screening and Typing, by Type, 2017
Figure 173 : Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
Figure 174 : Global Market Shares for Donor Blood Testing Equipment, by Region, 2017
Figure 175 : Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
Figure 176 : Global Market Shares for Patient Blood Testing Equipment, by Region, 2017
Figure 177 : Global Market for Blood Screening and Typing, by Region, 2017-2023
Figure 178 : Global Market Shares for Blood Screening and Typing, by Region, 2017
Figure 179 : North American Market for Blood Screening and Typing, by Country, 2017-2023
Figure 180 : North American Market Shares for Blood Screening and Typing, by Country, 2017
Figure 181 : European Market for Blood Screening and Typing, by Country, 2017-2023
Figure 182 : European Market Shares for Blood Screening and Typing, by Country, 2017
Figure 183 : Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
Figure 184 : Asia-Pacific Market Shares for Blood Screening and Typing, by Country, 2017
Figure 185 : RoW Market for Blood Screening and Typing, by Country, 2017-2023
Figure 186 : RoW Market Shares for Blood Screening and Typing, by Country, 2017
Figure 187 : Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
Figure 188 : Nucleic Acid Test Market Share Analysis, by Company, 2017
Figure 189 : Immunoassay Tests Market Share Analysis, by Company, 2017
Figure 190 : Immunohematology Market Share Analysis, by Company, 2017
Figure 191 : Microbiology Market Share Analysis, by Company, 2017

Pharmacy Retail Market in India 2019

Pharmacy Retail Market in India 2019 market research report available in single user pdf license with Aarkstore Enterprise at USD 950

USD 950 View Report

Surgical Robotics Market in India 2019

Surgical Robotics Market in India 2019 market research report available in single user pdf license with Aarkstore Enterprise at USD 950

USD 950 View Report

2019 Healthcare Market Intelligence: Leading Companies Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the

USD 6500 View Report

2019 Healthcare Competitive Intelligence: Allscripts Healthcare Solutions Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available